University Of Utah is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Location: Salt Lake City, Utah, USA
Type: Public Research University
Founded: 1850
Website: [utah.edu](https://www.utah.edu)
Neurodegeneration Focus: Department of Neurology, Center for Alzheimer's Care
The University of Utah is a public research university and the flagship institution of Utah. The Department of Neurology and Center for Alzheimer's Care are major centers for neurodegeneration research, with particular strengths in genetics, biomarker research, and clinical care.
A comprehensive center focused on:
- Patient care and clinical trials
- Biomarker research
- Genetic studies
- Caregiver support
Genetics and Genomics:
- Huntington's disease genetics
- Parkinson's disease genetics
- ALS genetics
- Rare neurodegenerative disorders
Biomarker Development:
- CSF biomarkers
- Blood-based biomarkers
- Neuroimaging markers
- Early detection methods
Therapeutic Development:
- Novel drug targets
- Gene therapy approaches
- Immunotherapy
- Alzheimer's Disease: Clinical care, biomarkers, clinical trials
- Parkinson's Disease: Genetic studies, movement disorders
- Huntington's Disease: Landmark genetic research, clinical trials
- ALS: Genetic factors, therapeutic development
University of Utah researchers discovered or contributed to understanding:
- Multiple genes for ALS (SOD1, others)
- Huntington's disease gene (HTT)
- Parkinson's disease genetic risk factors
- Various rare neurodegenerative disorders
- Huntington's Disease Center of Excellence: Comprehensive care and research
- Parkinson's Disease Center: Movement disorder specialists
- Clinical Trials Unit: Phase I-III trials
Research on this gene has revealed important insights into neurodegenerative disease mechanisms and therapeutic targets.
- Understanding how gene variants contribute to disease pathogenesis
- Protein dysfunction and aggregation pathways
- Impact on neuronal survival and function
- Interactions with other disease-related proteins
- Identification of novel drug targets
- Development of targeted therapies
- Biomarker development for diagnosis and progression
- Gene therapy and CRISPR-based approaches
- Ongoing clinical studies and trials
- Biomarker validation studies
- Natural history studies
- Translational research initiatives
The study of University Of Utah has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Center for Alzheimer's Care. University of Utah. https://healthcare.utah.edu
- The Huntington's Disease Collaborative Research Project. New England Journal of Medicine. 1993.
- Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial ALS. Nature. 1993.
- Polymeropoulos MH, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science. 1996.
The University of Utah houses the Center for Alzheimer's Care, Imaging and Research, the Neuroscience Initiative, and the Utah Alzheimer's Center. The University's computational biology and genomics programs complement neurodegenerative disease research.
The University of Utah offers graduate programs through the School of Medicine and the Department of Neurology. The Intermountain Healthcare partnership provides unique clinical research opportunities.
The University of Utah was founded in 1850 as the University of Deseret, making it the oldest continuously operating university in the western United States. The School of Medicine was established in 1900, and the Neurology Department has grown to become a leading center for neurodegenerative disease research, particularly in Huntington's disease and Parkinson's disease.
The University of Utah offers comprehensive training:
- Neurology Residency Program (4 years)
- Movement Disorders Fellowship
- Cognitive Neurology Fellowship
- Neuroscience PhD Program
- Postdoctoral positions in neurodegeneration research
Key facilities include:
- Brain Institute at the University of Utah
- Center for Alzheimer's Care, Imaging and Research
- Parkinson's Disease Center of Excellence
- HSC Core facilities for molecular biology
- Human neuroimaging center
University of Utah researchers have contributed to:
- Identification of Huntington's disease gene (HTT)
- Discovery of genetic modifiers in neurodegenerative diseases
- Development of novel therapeutic approaches
- Understanding of protein aggregation mechanisms
- Clinical trials for disease-modifying therapies
- Huntington's Disease
- Parkinson's Disease
- Alzheimer's Disease
- ALS
- Ataxias
- Dementias
The University of Utah collaborates with:
- Intermountain Healthcare
- VA Salt Lake City Health Care System
- NIH research consortia
- International neurodegeneration research networks
- University of Utah Neurology Department. https://medicine.utah.edu/neurology
- Brain Institute. https://brain.utah.edu